栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/02/03 | 1,581 | 1,585 | 1,573 | 1,585 | -4 | -0.3% | 114,900 |
| 2023/02/02 | 1,607 | 1,607 | 1,580 | 1,589 | -19 | -1.2% | 201,400 |
| 2023/02/01 | 1,600 | 1,614 | 1,582 | 1,608 | +20 | +1.3% | 199,600 |
| 2023/01/31 | 1,602 | 1,615 | 1,581 | 1,588 | -44 | -2.7% | 335,700 |
| 2023/01/30 | 1,650 | 1,657 | 1,630 | 1,632 | -10 | -0.6% | 189,800 |
| 2023/01/27 | 1,670 | 1,673 | 1,635 | 1,642 | -25 | -1.5% | 144,500 |
| 2023/01/26 | 1,668 | 1,668 | 1,653 | 1,667 | +9 | +0.5% | 135,200 |
| 2023/01/25 | 1,653 | 1,669 | 1,642 | 1,658 | +6 | +0.4% | 133,500 |
| 2023/01/24 | 1,632 | 1,654 | 1,621 | 1,652 | +28 | +1.7% | 115,100 |
| 2023/01/23 | 1,619 | 1,624 | 1,603 | 1,624 | +25 | +1.6% | 102,300 |
| 2023/01/20 | 1,609 | 1,609 | 1,592 | 1,599 | -7 | -0.4% | 127,800 |
| 2023/01/19 | 1,613 | 1,618 | 1,595 | 1,606 | -14 | -0.9% | 164,700 |
| 2023/01/18 | 1,585 | 1,620 | 1,585 | 1,620 | +43 | +2.7% | 109,500 |
| 2023/01/17 | 1,590 | 1,594 | 1,566 | 1,577 | -12 | -0.8% | 170,000 |
| 2023/01/16 | 1,598 | 1,603 | 1,581 | 1,589 | -27 | -1.7% | 145,100 |
| 2023/01/13 | 1,636 | 1,643 | 1,610 | 1,616 | -26 | -1.6% | 113,300 |
| 2023/01/12 | 1,643 | 1,657 | 1,626 | 1,642 | -1 | -0.1% | 125,300 |
| 2023/01/11 | 1,623 | 1,657 | 1,622 | 1,643 | +23 | +1.4% | 155,000 |
| 2023/01/10 | 1,638 | 1,646 | 1,618 | 1,620 | -22 | -1.3% | 91,800 |
| 2023/01/06 | 1,635 | 1,644 | 1,625 | 1,642 | +11 | +0.7% | 79,000 |
| 2023/01/05 | 1,638 | 1,640 | 1,613 | 1,631 | -25 | -1.5% | 113,100 |
| 2023/01/04 | 1,704 | 1,704 | 1,654 | 1,656 | -53 | -3.1% | 117,300 |
| 2022/12/30 | 1,697 | 1,721 | 1,696 | 1,709 | -6 | -0.3% | 208,000 |
| 2022/12/29 | 1,715 | 1,720 | 1,699 | 1,715 | +5 | +0.3% | 191,100 |
| 2022/12/28 | 1,715 | 1,715 | 1,696 | 1,710 | -24 | -1.4% | 167,200 |
| 2022/12/27 | 1,718 | 1,743 | 1,713 | 1,734 | +31 | +1.8% | 183,800 |
| 2022/12/26 | 1,710 | 1,716 | 1,691 | 1,703 | ±0 | ±0% | 144,500 |
| 2022/12/23 | 1,720 | 1,720 | 1,696 | 1,703 | -32 | -1.8% | 134,300 |
| 2022/12/22 | 1,737 | 1,745 | 1,724 | 1,735 | -18 | -1% | 127,100 |
| 2022/12/21 | 1,771 | 1,783 | 1,730 | 1,753 | -32 | -1.8% | 172,700 |
| 2022/12/20 | 1,853 | 1,858 | 1,771 | 1,785 | -60 | -3.3% | 321,200 |
| 2022/12/19 | 1,819 | 1,846 | 1,819 | 1,845 | +7 | +0.4% | 123,000 |
| 2022/12/16 | 1,838 | 1,855 | 1,831 | 1,838 | -14 | -0.8% | 133,500 |
| 2022/12/15 | 1,863 | 1,864 | 1,851 | 1,852 | -12 | -0.6% | 28,300 |
| 2022/12/14 | 1,852 | 1,870 | 1,850 | 1,864 | +24 | +1.3% | 105,800 |
| 2022/12/13 | 1,850 | 1,862 | 1,837 | 1,840 | -14 | -0.8% | 67,000 |
| 2022/12/12 | 1,853 | 1,860 | 1,839 | 1,854 | +2 | +0.1% | 69,700 |
| 2022/12/09 | 1,837 | 1,854 | 1,824 | 1,852 | +29 | +1.6% | 76,500 |
| 2022/12/08 | 1,819 | 1,833 | 1,808 | 1,823 | +6 | +0.3% | 84,700 |
| 2022/12/07 | 1,787 | 1,826 | 1,782 | 1,817 | +33 | +1.8% | 78,200 |
| 2022/12/06 | 1,790 | 1,796 | 1,775 | 1,784 | -12 | -0.7% | 75,500 |
| 2022/12/05 | 1,821 | 1,821 | 1,788 | 1,796 | -30 | -1.6% | 85,200 |
| 2022/12/02 | 1,865 | 1,866 | 1,825 | 1,826 | -51 | -2.7% | 104,800 |
| 2022/12/01 | 1,906 | 1,906 | 1,866 | 1,877 | -26 | -1.4% | 72,200 |
| 2022/11/30 | 1,917 | 1,917 | 1,889 | 1,903 | -30 | -1.6% | 119,700 |
| 2022/11/29 | 1,941 | 1,951 | 1,922 | 1,933 | -20 | -1% | 106,300 |
| 2022/11/28 | 1,979 | 1,979 | 1,943 | 1,953 | -38 | -1.9% | 129,600 |
| 2022/11/25 | 1,986 | 1,998 | 1,981 | 1,991 | +15 | +0.8% | 87,500 |
| 2022/11/24 | 1,960 | 1,987 | 1,960 | 1,976 | +16 | +0.8% | 91,000 |
| 2022/11/22 | 1,950 | 1,979 | 1,946 | 1,960 | +16 | +0.8% | 181,600 |
551～
600
件表示中 / 6947件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 221,000円 | +0.4% | -8.4% | 2.40% | 28.37倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 307,000円 | +3.0% | +27.5% | 2.61% | 19.43倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 147,000円 | +8.8% | +99.9% | 3.54% | 9.39倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 90,100円 | +22.8% | - | 0.00% | 73.61倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| あすかＨＤ | 230,600円 | +0.3% | +2.7% | 2.17% | 13.08倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
